In contrast, our findings indicate that in osteoblasts, CXCL1 activates the TGF‐β signalling pathway to inhibit apoptosis, suggesting a possible reciprocal relationship between CXCL1 and TGF‐β signalling in osteoblasts and tumour cells. Here, CXCL1 is linked to neoplasm.